Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells

Journal of Cellular Biochemistry

Volumn 112, Issue 8, 2011, Pages 2125-2137

  Li, Youqiang ^a   Zeng, Yu ^a   Mooney, Steven M ^a   Yin, Bo ^a   Mizokami, Atsushi ^b   Namiki, Mikio ^b   Getzenberg, Robert H ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Drug resistance; Heat; Microenvironment; Microenvironmental stress; Prostate cancer

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM BINDING PROTEIN; CASPASE 3; GLUCOSE; PACLITAXEL; POTASSIUM ION; SODIUM ION;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CELLULAR STRESS RESPONSE; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; GENE OVEREXPRESSION; HEAT SENSITIVITY; HEAT STRESS; HUMAN; HUMAN CELL; IC 50; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR MICROENVIRONMENT; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DRUG RESISTANCE, NEOPLASM; HOT TEMPERATURE; HUMANS; HYPERTHERMIA, INDUCED; MALE; PACLITAXEL; PROSTATIC NEOPLASMS; STRESS, PHYSIOLOGICAL;

EID: 79960372436     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23134     Document Type: Article

References (39)

1. Amellem O, Pettersen EO,. 1991. The role of protein accumulation on the kinetics of entry into S phase following extreme hypoxia. Anticancer Res 11: 1083-1087.
2. Becker A, Stadler P, Lavey RS, Hansgen G, Kuhnt T, Lautenschlager C, Feldmann HJ, Molls M, Dunst J,. 2000. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 46: 459-466. (Pubitemid 30067797)
3. Belka C, Jendrossek V, Pruschy M, Vink S, Verheij M, Budach W,. 2004. Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. Int J Radiat Oncol Biol Phys 58: 542-554. (Pubitemid 38142482)
4. Carrafiello G, Lagana D, Mangini M, Fontana F, Dionigi G, Boni L, Rovera F, Cuffari S, Fugazzola C,. 2008. Microwave tumors ablation: Principles, clinical applications and review of preliminary experiences. Int J Surg 6 (Suppl 1): S65-S69.
5. Chopra R, Tang K, Burtnyk M, Boyes A, Sugar L, Appu S, Klotz L, Bronskill M,. 2009. Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback. Phys Med Biol 54: 2615-2633.
6. Civan MM,. 2010. Transporters beyond transport. Focus on "Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: Role of chloride channels ". Am J Physiol Cell Physiol 298: C11-C13.
7. Coffey DS, Getzenberg RH, DeWeese TL,. 2006. Hyperthermic biology and cancer therapies: A hypothesis for the "Lance Armstrong effect ". JAMA 296: 445-448. (Pubitemid 44127529)
8. Collingridge DR, Piepmeier JM, Rockwell S, Knisely JP,. 1999. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 53: 127-131.
9. Dannenberg JH, Berns A,. 2010. Drugging drug resistance. Cell 141: 18-20.
10. Fiegl H, Millinger S, Goebel G, Muller-Holzner E, Marth C, Laird PW, Widschwendter M,. 2006. Breast cancer DNA methylation profiles in cancer cells and tumor stroma: Association with HER-2/neu status in primary breast cancer. Cancer Res 66: 29-33. (Pubitemid 43166004)
11. Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT,. 1994. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res 54: 6167-6175.
12. Gopalkrishnan RV, Kang DC, Fisher PB,. 2001. Molecular markers and determinants of prostate cancer metastasis. J Cell Physiol 189: 245-256. (Pubitemid 33063292)
13. Horsman MR,. 1995. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review. Acta Oncol 34: 571-587.
14. Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, Polyak K,. 2005. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 37: 899-905. (Pubitemid 41077119)
15. Hunter A, Hendrikse A, Renan M, Abratt R,. 2006. Does the tumor microenvironment influence radiation-induced apoptosis? Apoptosis 11: 1727-1735. (Pubitemid 44371048)
16. Jemal A, Siegel R, Xu J, Ward E,. 2010. Cancer statistics. CA Cancer J Clin 60: 277-300.
17. Johnstone SE, Baylin SB,. 2010. Stress and the epigenetic landscape: A link to the pathobiology of human diseases? Nat Rev Genet 11: 806-812.
18. Krishnan S, Diagaradjane P, Cho SH,. 2010. Nanoparticle-mediated thermal therapy: Evolving strategies for prostate cancer therapy. Int J Hyperthermia 26: 775-789.
19. Leaf A,. 1956. On the mechanism of fluid exchange of tissues in vitro. Biochem J 62: 241-248.
20. Li Y, Mizokami A, Izumi K, Narimoto K, Shima T, Zhang J, Dai J, Keller ET,., Namiki M,. 2010. CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer. Prostate 70: 48-60.
21. Mashima T, Sato S, Sugimoto Y, Tsuruo T, Seimiya H,. 2009. Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions. Oncogene 28: 9-19.
22. McTaggart RA, Dupuy DE,. 2007. Thermal ablation of lung tumors. Tech Vasc Interv Radiol 10: 102-113. (Pubitemid 350216511)
23. +-ATPase is the Achilles heel of multi-drug-resistant cancer cells. Cancer Lett 282: 30-34.
24. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL,. 2004. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 209: 171-176. (Pubitemid 38670486)
25. Oudard S, Banu E, Beuzeboc P, Voog E, Dourthe LM, Hardy-Bessard AC, Linassier C, Scotte F, Banu A, Coscas Y, Guinet F, Poupon MF, Andrieu JM,. 2005. Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer. J Clin Oncol 23: 3343-3351.
26. Pardal R, Clarke MF, Morrison SJ,. 2003. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3: 895-902. (Pubitemid 37500174)
27. Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED,. 2004. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351: 1513-1520. (Pubitemid 39315318)
28. Pflug BR, Reiter RE, Nelson JB,. 1999. Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines. Prostate 40: 269-273. (Pubitemid 29398054)
29. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA, Wong KK, Brandstetter K, Wittner B, Ramaswamy S, Classon M, Settleman J,. 2010. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141: 69-80.
30. Simpson CD, Mawji IA, Anyiwe K, Williams MA, Wang X, Venugopal AL, Gronda M, Hurren R, Cheng S, Serra S, Beheshti Zavareh R, Datti A, Wrana JL, Ezzat S, Schimmer AD,. 2009. Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation. Cancer Res 69: 2739-2747.
31. Swietach P, Vaughan-Jones RD, Harris AL,. 2007. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev 26: 299-310. (Pubitemid 47101667)
32. Takeda M, Mizokami A, Mamiya K, Li YQ, Zhang J, Keller ET, Namiki M,. 2007. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines. Prostate 67: 955-967. (Pubitemid 46828929)
33. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Theodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA,. 2004. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351: 1502-1512. (Pubitemid 39315317)
34. Vaupel PW, Frinak S, Bicher HI,. 1981. Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Res 41: 2008-2013. (Pubitemid 11114612)
35. Vaupel P, Kelleher DK, Hockel M,. 2001. Oxygen status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 28: 29-35. (Pubitemid 32522235)
36. Vaupel P, Mayer A, Briest S, Hockel M,. 2003. Oxygenation gain factor: A novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. Cancer Res 63: 7634-7637. (Pubitemid 37466687)
37. Wilson TH,. 1954. Ionic permeability and osmotic swelling of cells. Science 120: 104-105.
38. Yuan J, Narayanan L, Rockwell S, Glazer PM,. 2000. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res 60: 4372-4376. (Pubitemid 32103614)
39. Zeng Y, Kulkarni P, Inoue T, Getzenberg RH,. 2009. Down-regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity. J Cell Biochem 107: 179-188.